CEO of Ptc Therapeutics Inc (30-Year Financial, Insider Trades) Stuart Walter Peltz (insider trades) sold 33,788 shares of PTCT on 05/20/2020 at an average price of $50 a share. The total sale was $1.7 million.
PTC Therapeutics Inc is a biopharmaceutical company. It is focused on the discovery and development of orally administered, proprietary small-molecule drugs that target post-transcriptional control processes. PTC Therapeutics Inc has a market cap of $3.32 billion; its shares were traded at around $50.61 with and P/S ratio of 9.30. PTC Therapeutics Inc had annual average EBITDA growth of 14.00% over the past five years. GuruFocus has detected 2 severe warning signs with PTC Therapeutics Inc. .
CEO Recent Trades:
- CEO Stuart Walter Peltz sold 33,788 shares of PTCT stock on 05/20/2020 at the average price of $50. The price of the stock has increased by 1.22% since.
- CEO Stuart Walter Peltz sold 6,284 shares of PTCT stock on 05/18/2020 at the average price of $50.12. The price of the stock has increased by 0.98% since.
- CEO Stuart Walter Peltz sold 109,928 shares of PTCT stock on 05/05/2020 at the average price of $50.34. The price of the stock has increased by 0.54% since.
For the complete insider trading history of PTCT, click here
.
